<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="treatment.css">
    <link rel="shortcut icon" href="files/favicon.ico" type="image/x-icon">
    <link href='https://unpkg.com/boxicons@2.1.4/css/boxicons.min.css' rel='stylesheet'>
    <title>Diabetes</title>
</head>
<body>
    <header class="header">
        <a href="index.html" class="logo"><img src="images/logo.png" alt="">Diabetes</a>
        <nav class="navbar">
            <a href="index.html">Home</a>
            <a href="about.html">About</a>
            <a href="resources.html">Resources</a>
            <a href="news.html">News</a>
            <a href="tools.html">Tools</a>
            <a href="treatment.html" class="active">Treatment</a>
            <a href="consultation.html">Consultation</a>
            <a href="login.html">Login</a>
        </nav>
    </header>
    <div class="section1">
        <div class="s1-left">
            <div class="s1-heading">
                Latest Treatment
            </div>
            <div class="s1-para">Continuous Glucose Monitoring (CGM) Systems: CGM systems have seen significant advancements, offering more accurate and convenient glucose monitoring for diabetes management. These systems continuously measure glucose levels throughout the day and night, providing real-time data to users and healthcare providers.</div>
            <div class="s1-para">Closed-Loop Insulin Delivery Systems (Artificial Pancreas): Closed-loop insulin delivery systems, also known as artificial pancreas systems, have made significant strides in recent years. These systems use CGM data to automatically adjust insulin delivery through an insulin pump, providing more precise control of blood glucose levels and reducing the risk of hypoglycemia. </div>
            <div class="s1-para">Insulin Analogues: Advances in insulin analogues have led to the development of faster-acting and longer-lasting formulations, providing more flexibility and convenience in insulin therapy. Ultra-rapid-acting insulins, such as Fiasp (insulin aspart), offer quicker onset and shorter duration of action, allowing for more precise mealtime dosing. </div>
            <div class="s1-para">Oral Semaglutide: Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was previously available only as a once-weekly injectable medication for the treatment of type 2 diabetes. However, a recent innovation is the development of an oral formulation of semaglutide, which offers the same efficacy in glycemic control as the injectable version but in a convenient oral tablet form.</div>
            <div class="s1-para">Gene Therapy and Stem Cell Research: There is ongoing research into the use of gene therapy and stem cell-based approaches for the treatment of diabetes. These innovative treatments aim to regenerate pancreatic beta cells, restore insulin production, and improve glucose metabolism in patients with diabetes.</div>
            <div class="s1-link">
                <div class="s1-link-heading">
                    <a href="consultation.html">Consult a doctor?</a>
                </div>
            </div>
        </div>
        <div class="s1-right">
            <div class="s1-heading">
                Current Research
            </div>
            <div class="s1-para">Personalized Medicine: There's a growing interest in personalized approaches to diabetes management, including genetics, lifestyle factors, and individualized treatment plans based on patient characteristics.</div>
            <div class="s1-para">New Insulin Formulations and Delivery Methods: Researchers are exploring novel insulin formulations and delivery methods to improve convenience, efficacy, and safety for diabetes patients, including oral insulin, inhalable insulin, and faster-acting insulins.</div>
            <div class="s1-para">Cellular Therapies and Regenerative Medicine: Investigating the potential of stem cell therapies, islet cell transplantation, and other regenerative medicine approaches to restore pancreatic function in type 1 diabetes and improve insulin sensitivity in type 2 diabetes.
            </div>
            <div class="s1-para">Artificial Intelligence and Machine Learning: Utilizing AI and machine learning algorithms to analyze large datasets for better prediction, diagnosis, and management of diabetes-related complications, as well as optimizing treatment strategies.</div>
            <div class="s1-para">Metabolic Surgery: Research into the effects of metabolic (bariatric) surgery on diabetes remission and long-term glycemic control, particularly in individuals with obesity and type 2 diabetes. Studies focusing on lifestyle interventions, early detection, and prevention strategies to delay or prevent the onset of type 2 diabetes, as well as identifying biomarkers for early diagnosis and risk stratification.</div>
            <div class="s1-para">Targeted Therapies for Type 2 Diabetes: Investigating new drug targets and therapies for type 2 diabetes, SGLT-2 inhibitors, and other pharmacological agents to improve glucose control and reduce cardiovascular risk.</div>
            <div class="s1-link">
                <div class="s1-link-heading">
                    <a href="resources.html">Check resources</a>
                </div>
            </div>
        </div>
        
    </div>
    <footer>
        <div class="bottomSection">
            <a href="index.html" class="logo"><img src="images/logo.png" alt="">Diabetes</a>
            <div class="home-sci">
                <a href=""><i class='bx bxl-facebook'></i></a>
                <a href=""><i class='bx bxl-twitter' ></i></a>
                <a href=""><i class='bx bxl-linkedin'></i></a>
            </div>
            <div class="bottomSection2">
                <a href="index.html">www.diabetes.com</a>
            </div>
        </div>
    </footer>
    </body>
    </html>